John A Hyland, M.D. Radiology - Therapeutic Radiology Medicare: Accepting Medicare Assignments Practice Location: 3204 Johnson Rd, Steubenville, OH 43952 Phone: 724-264-8700 Fax: 740-264-8796 |
Jae M Koh, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 |
Dr. Christopher Thomas Hunnicutt, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 |
William H Vaughan, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8288 Fax: 740-264-8622 |
Heung J Yoo, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8288 Fax: 740-264-8622 |
Jeffrey R Clark, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 |
Ronald I Veatch, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8288 Fax: 740-264-8622 |
Belen P Vargas, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8288 Fax: 740-264-8622 |
Prem S Srivastava, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Johnson Rd, Steubenville, OH 43952 Phone: 740-264-8287 Fax: 740-264-8622 |
News Archive
Critical Signal Technologies, Inc. (CST) has acquired the stock and assets of GTL, Inc. dba as "Link to Life" along with Link Technologies, Inc., and will integrate its product and service offerings into CST to provide cost-effective personal emergency response, TeleHealth and medical monitoring systems, improving the independence and quality of life for older adults, the disabled and people managing health conditions.
Neuralstem, Inc. announced today that it has raised a total of $5,228,000 since the beginning of the year, comprised of a previously disclosed $1.5 million private placement of 646,551 common shares at $2.32, priced at a 30 percent premium over the market on the closing, and approximately $3.7 million from warrant exercises.
New treatments for dry eye disease that deliver lipids to the ocular surface are designed to more closely mimic the important tear film lipid layer at the air-water interface in the eye.
"U.S. government officials say they expect to put the finishing touches this month on new rules designed to help funding agencies identify and regulate especially problematic H5N1 studies before they begin," which would allow influenza researchers "to lift a year-old, self-imposed moratorium on certain kinds of potentially dangerous experiments," Science reports.
› Verified 4 days ago